New biomarker data from BEXMAB study at EHA2023
Gilteritinib as Maintenance Therapy Demonstrated Benefit in Subgroups of FLT3-ITD Acute Myeloid Leukemia Patients
Insect Repellent Active Ingredients Market worth $1.5 billion by 2028
China Approves the World’s First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use
Pharmaceutical contract research and manufacturing (CRAM) market size to grow by USD 121.35 billion from 2022 to 2027; The availability of cost-efficient resources in emerging markets to be a major driver
America’s Best Wings: Everything You Need to Know
Watch out for tick bites… at home!
Ehpad: families still do not find their account
Bonrepos-Riquet. See you at the castle for a nice gesture
Launaguet. Big blood drive for three days
Ledat. "LEA 47" Fight Together Differently
Faron Pharmaceuticals Oy (“Faron” or “the Company”) Faron Announces New Biomarker Data from Phase I/II BEXMAB Study at EHA2023 Hybrid Congress Bexmarilimab mode of action in AML/MDS...